Search

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility.

… Tuesday, December 10, 2019 The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility. “Safety, coupled with a healthy indoor environment, is the most important assurance we can offer patients, which

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.

… Friday, July 6, 2012 Summary A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells. Doctors who treat patients with breast cancer have known that

Lisa M. DeAngelis, MD and Elizabeth Schille, RN, OCN were recognized for their work in the the field of neuro-oncology.

… Friday, November 6, 2020 Memorial Sloan Kettering (MSK) Physician-in-Chief and Chief Medical Officer  Lisa M. DeAngelis, MD , has been awarded Oligo Nation’s Lifetime Achievement Award for her leadership in the field of neuro-oncology. MSK Registered Nurse Elizabeth Schille, RN, OCN, was also honored

The President and CEO and Chair of the Board at Memorial Sloan Kettering Cancer Center introduce the year's highlights in their introductory letter to the 2023 Annual Report.

… Monday, June 10, 2024 Every day, the people of Memorial Sloan Kettering Cancer Center (MSK) are driven by a singular mission: ending cancer for life. That relentless focus enables us to provide the world’s best, most compassionate care to every person who comes to MSK. It is what propels us to transform

The Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial demonstrated that the watch-and-wait strategy is safe for patients with stage 2 and stage 3 rectal cancers that achieve a clinical complete response (CCR) or near-complete clinical response (NCR) to total neoadjuvant therapy (TNT).

… Tuesday, February 13, 2024 The Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial demonstrated that the watch-and-wait strategy is safe for patients with stage 2 and stage 3 rectal cancers that achieve a clinical complete response (CCR) or near-complete clinical response (NCR) to

MSK researchers have identified a compound that kills glioblastoma cells using a mechanism that’s completely different from earlier treatments.

… Wednesday, March 6, 2019 Summary Using genetically engineered mouse models and high-throughput screening technologies, MSK researchers have found a surprising new approach for targeting glioblastoma. It involves focusing in on cancer stem cells. The type of brain tumor known as glioblastoma (GBM) is

Every year, GSK awards fellowships to two third-year students and six second-year students based on academic excellence.

… Tuesday, August 29, 2017 Gerstner Sloan Kettering (GSK) Graduate School student stipends are supported by a variety of sources including philanthropic fellowships. Every year, GSK awards fellowships to two third-year students and six second-year students based on academic excellence. Grayer Fellows Third-year

Kathryn was honored with The Leon J. Warshaw Leadership in Healthcare Award.

… Wednesday, December 15, 2021 Kathryn Martin , Chief Operating Officer of Memorial Sloan Kettering Cancer Center, was selected to receive this year’s The Leon J. Warshaw Leadership in Healthcare Award from the Northeast Business Group on Health (NEGBH). The award celebrates extraordinary service, leadership

Emerging evidence shows that immediate autologous breast reconstruction can tolerate radiotherapy better than previously thought in select cases.

… Wednesday, April 18, 2018 Emerging evidence shows that immediate autologous breast reconstruction can tolerate radiotherapy better than previously thought in select cases. Radiation can have major deleterious effects on the cosmetic outcomes of reconstructive procedures.  (1) As a result, the timing

Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.

… Monday, October 4, 2021 At first, Mikaela Rix was not worried about the tiny lump in her breast. It felt like a frozen pea, and she assumed it was a benign cyst. A former Boston College lacrosse player, 26-year-old Mikaela assumed she was in perfect health. She became uneasy when the radiologist looked